Ashley Morgan

Audits of Semaglutide and Other GLP-1 Claims are Increasing

Prescriber Risks Ordering Semaglutide, Tirzepatide and Other Compounded GLP-1 Medications

(October 24, 2024): Semaglutide, tirzepatide and a slate of other GLP-1 receptor agonist medications have dominated weight loss headlines in recent years. Not surprisingly, many weight loss providers and clinics have refocused their approaches, incorporating these drugs into patient treatment regimens. Unfortunately, the popularity of these drugs has led to a variety of bad practices, […]

Prescriber Risks Ordering Semaglutide, Tirzepatide and Other Compounded GLP-1 Medications Read More »

Health Care Provider Risks of Chelation Therapy - Liles Parker

Health Care Provider Risks When Ordering and Billing Chelation Therapy Services

(January 25, 2024): Although chelation therapy[1] has played an important role in mainstream medicine for many years,[2] it is still considered by many clinicians and regulators to fall within the category of “Complementary and Alternative Medicine.” Proponents of chelation therapy in alternative medicine practices have supported its use in treating Alzheimer’s disease,[3] Parkinson’s disease, multiple

Health Care Provider Risks When Ordering and Billing Chelation Therapy Services Read More »

Hospice Audit and Investigative Actions are Expected to Rise in 2024 - November 2023

Hospice Audit and Investigative Actions are Expected to Rise in 2024

(November 20, 2023): Medicare, Medicaid, and most private insurance plans cover hospice care and related services. To be eligible for hospice care,[1] a patient must be certified as terminally ill and have a life expectancy of six months or less.  In recent years, the hospice industry has exponentially grown, and the number of Federal, State

Hospice Audit and Investigative Actions are Expected to Rise in 2024 Read More »

Medicare Advantage SIU Audits and Investigations are More Prevalent Than Ever

Author: Ashley Morgan, Annabella Denzel (April 5, 2023): In the sphere of healthcare compliance, providers must manage audits coming from every possible authority whether it be from public agencies, a private payor, or other third-party authorities. CMS has announced that the FY 2022 fee-for-service improper payment rate was 7.46%.[1] While this is a slight increase

Medicare Advantage SIU Audits and Investigations are More Prevalent Than Ever Read More »

Inflation Reduction Act: What is the Impact on Healthcare Providers?

Author: Ashley Morgan, Annabella Denzel (March 30, 2023): On August 16, 2022,[1] President Biden signed the Inflation Reduction Act (IRA) into law, bringing with it plans for broad sweeping changes to tax rates, energy prices, and—most importantly for our purposes — healthcare costs. The general consensus from providers is that because the IRA’s healthcare related

Inflation Reduction Act: What is the Impact on Healthcare Providers? Read More »

Amniotic Fluid / Amniotic Membrane Tissue Audits, Investigations and Prosecutions are Continuing to Climb in 2022

(August 4, 2022): Over the past year, we have seen a significant increase in the number of Medicare administrative audits, False Claims Act investigations and criminal prosecutions by the Department of Justice (DOJ), related to the billing of allogeneic (harvested from someone else) stem cell products. Medicare and Medicaid claims stemming from amniotic liquid and

Amniotic Fluid / Amniotic Membrane Tissue Audits, Investigations and Prosecutions are Continuing to Climb in 2022 Read More »

The Coronavirus Aid, Relief and Economic Security (CARES) Act: Provisions Relevant to Healthcare Providers

By Michael Cook, Jennifer Papapanagiotou & Andy Lynch –  Partners at Liles Parker, PLLC. (March 31, 2020):  On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (CARES) Act[1] passed the House of Representatives by a voice vote. The President then signed the bill into law. The bill is the third round of federal

The Coronavirus Aid, Relief and Economic Security (CARES) Act: Provisions Relevant to Healthcare Providers Read More »

Small Business Administration Releases Express Bridge Loan Pilot Program for COVID-19

(March 26, 2020): The Small Business Administration (“SBA”) announced an Express Bridge Loan Pilot Program on March 25, 2020.[1] The Express Bridge Loans are available to businesses, including health care providers, to provide economic relief for businesses impacted by the Coronavirus Disease (COVID-19) while they await long-term disaster financing.[2] I. Background: The Express Bridge Loan

Small Business Administration Releases Express Bridge Loan Pilot Program for COVID-19 Read More »

Lab Testing Guidance for COVID-19

(Updated March 31, 2020): On March 13, 2020, President Trump declared a National Emergency[1] related to the current Coronavirus / COVID-19 outbreak. The declaration gives Secretary Alex Azar of the U.S. Department of Health & Human Services (HHS) the power to waive certain Federal requirements in Medicare, Medicaid and CHIP in order to address the

Lab Testing Guidance for COVID-19 Read More »